119 related articles for article (PubMed ID: 16786662)
21. [Systemic enzymotherapy in the combined treatment of infectious endocarditis in drug addicts].
Ulanova VI; Mazurov VI
Klin Med (Mosk); 2011; 89(2):53-5. PubMed ID: 21574445
[TBL] [Abstract][Full Text] [Related]
22. [The favorable effect of hydrolytic enzymes in the treatment of immunocytomas and plasmacytomas].
Sakalová A; Mikulecký M; Holománová D; Langner D; Ransberger K; Stauder G; Mistrík M; Gazová S; Chabronová I; Benzová M
Vnitr Lek; 1992 Sep; 38(9):921-9. PubMed ID: 1481392
[TBL] [Abstract][Full Text] [Related]
23. Efficacy of Wobe-Mugos E for reduction of oral mucositis after radiotherapy : results of a prospective, randomized, placebo-controlled, triple-blind phase III multicenter study.
Dörr W; Herrmann T;
Strahlenther Onkol; 2007 Mar; 183(3):121-7. PubMed ID: 17340069
[TBL] [Abstract][Full Text] [Related]
24. Enzymes, trophoblasts, and cancer: the afterlife of an idea (1924-2008).
Moss RW
Integr Cancer Ther; 2008 Dec; 7(4):262-75. PubMed ID: 19116222
[TBL] [Abstract][Full Text] [Related]
25. [Results of the use of an oral trypsin-chymotrypsin combination in gynecologic therapy].
Tozzi T; Lauda N
Minerva Ginecol; 1972; 24(8):405-9. PubMed ID: 4603804
[No Abstract] [Full Text] [Related]
26. [Use of WOBE-MUGOS E for prevention and correction of experimental doxorubicin side-effects].
Todor IN; Solianik GI; Iurchenko OV; Shpilevaia SI; Luk'ianova NIu; Trindiak VP; Kunskaia LN; Ponomareva OV; Terzov AI; Kulik GI; Chekhun VF
Lik Sprava; 2001; (3):116-21. PubMed ID: 11559997
[TBL] [Abstract][Full Text] [Related]
27. [Reducing pain by oral enzyme therapy in rheumatic diseases].
Klein G; Kullich W
Wien Med Wochenschr; 1999; 149(21-22):577-80. PubMed ID: 10666820
[TBL] [Abstract][Full Text] [Related]
28. [Local enzymotherapy in gynecology. Experimentation on trypsin in pressurized bottles and its application and local use in gynecology].
Magnier P
Rev Fr Gynecol Obstet; 1967; 62(4):243-57. PubMed ID: 5619223
[No Abstract] [Full Text] [Related]
29. [Systemic poly-enzyme therapy in prophylaxis of venous blood circulation disorder in the lower limbs in modern sport].
Sternin IuI; Safonov LV; Levando VA
Voen Med Zh; 2008 May; 329(5):42-5. PubMed ID: 18589703
[No Abstract] [Full Text] [Related]
30. Does prophylactic treatment with proteolytic enzymes reduce acute toxicity of adjuvant pelvic irradiation? Results of a double-blind randomized trial.
Martin T; Uhder K; Kurek R; Roeddiger S; Schneider L; Vogt HG; Heyd R; Zamboglou N
Radiother Oncol; 2002 Oct; 65(1):17-22. PubMed ID: 12413670
[TBL] [Abstract][Full Text] [Related]
31. Efficacy and tolerability of oral enzyme therapy as compared to diclofenac in active osteoarthrosis of knee joint: an open randomized controlled clinical trial.
Tilwe GH; Beria S; Turakhia NH; Daftary GV; Schiess W
J Assoc Physicians India; 2001 Jun; 49():617-21. PubMed ID: 11584936
[TBL] [Abstract][Full Text] [Related]
32. Efficacy and safety of phlogenzym--a protease formulation, in sepsis in children.
Shahid SK; Turakhia NH; Kundra M; Shanbag P; Daftary GV; Schiess W
J Assoc Physicians India; 2002 Apr; 50():527-31. PubMed ID: 12164403
[TBL] [Abstract][Full Text] [Related]
33. Enzymes as therapeutic agents.
Cooney DA; Rosenbluth RJ
Adv Pharmacol Chemother; 1975; 12(0):185-289. PubMed ID: 168755
[No Abstract] [Full Text] [Related]
34. [Antioxidant effect of wobenzym applied for patients with chronic glomerulonephritis].
Mukhin IV
Lik Sprava; 2007; (1-2):58-61. PubMed ID: 17684803
[TBL] [Abstract][Full Text] [Related]
35. Our experiences with combination of enzyme therapy and laser therapy in enthesopathies.
Zemanová K; Svítková-Herényiová D; Navrátil L; Foltýnová V
Sb Lek; 2000; 101(3):249-54. PubMed ID: 11220153
[TBL] [Abstract][Full Text] [Related]
36. [Experimental evaluation of the wound healing dynamics].
Minaev SV
Vestn Khir Im I I Grek; 2003; 162(4):57-62. PubMed ID: 14569780
[TBL] [Abstract][Full Text] [Related]
37. [Results of enzymotherapy in patients with suppurative lung diseases].
Struchkov VI; Bocharova VM
Grudn Khir; 1970; 12(4):47-52. PubMed ID: 5479813
[No Abstract] [Full Text] [Related]
38. [Systemic enzyme therapy as a method for potentiation of the effect of antibacterial agents].
Remezov AP; Knorring GIu
Antibiot Khimioter; 2003; 48(3):30-3. PubMed ID: 12914119
[No Abstract] [Full Text] [Related]
39. Where do the immunostimulatory effects of oral proteolytic enzymes ('systemic enzyme therapy') come from? Microbial proteolysis as a possible starting point.
Biziulevicius GA
Med Hypotheses; 2006; 67(6):1386-8. PubMed ID: 16870353
[TBL] [Abstract][Full Text] [Related]
40. [Clinical experience with a new enzyme preparation].
José GS
Schweiz Rundsch Med Prax; 1970 Sep; 59(37):1307-10. PubMed ID: 4253912
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
